[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Dermal Fillers and Botulinum Toxin Market Report 2017

October 2017 | 112 pages | ID: UDB0FFC7008PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Dermal Fillers and Botulinum Toxin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Dermal Fillers and Botulinum Toxin in these regions, from 2012 to 2022 (forecast).
United States Dermal Fillers and Botulinum Toxin market competition by top manufacturers/players, with Dermal Fillers and Botulinum Toxin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Allergan plc.
  • Galderma SA
  • Merz Pharma GmbH & Co. KGaA
  • Sanofi
  • Anika Therapeutics, Inc.
  • LG Life Sciences
  • Suneva Medical, Inc.
  • Hyaltech
  • Speciality European Pharma
  • HUGEL, Inc.
  • Grex Pharma SaS
  • Daewoong Pharmaceuticals
  • Medy-Tox Inc.
  • TEOXANE Laboratories
  • SciVision Biotech Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Hyaluronic Acid Based Dermal Fillers
  • Non-hyaluronic Acid Based Dermal Fillers
  • Botulinum Toxin
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dermal Fillers and Botulinum Toxin for each application, including
  • Aesthetic Volume Restoration
  • Wrinkle Reduction
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Dermal Fillers and Botulinum Toxin Market Report 2017

1 DERMAL FILLERS AND BOTULINUM TOXIN OVERVIEW

1.1 Product Overview and Scope of Dermal Fillers and Botulinum Toxin
1.2 Classification of Dermal Fillers and Botulinum Toxin by Product Category
  1.2.1 United States Dermal Fillers and Botulinum Toxin Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Dermal Fillers and Botulinum Toxin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Hyaluronic Acid Based Dermal Fillers
  1.2.4 Non-hyaluronic Acid Based Dermal Fillers
  1.2.5 Botulinum Toxin
1.3 United States Dermal Fillers and Botulinum Toxin Market by Application/End Users
  1.3.1 United States Dermal Fillers and Botulinum Toxin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Aesthetic Volume Restoration
  1.3.3 Wrinkle Reduction
1.4 United States Dermal Fillers and Botulinum Toxin Market by Region
  1.4.1 United States Dermal Fillers and Botulinum Toxin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Dermal Fillers and Botulinum Toxin Status and Prospect (2012-2022)
  1.4.3 Southwest Dermal Fillers and Botulinum Toxin Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Dermal Fillers and Botulinum Toxin Status and Prospect (2012-2022)
  1.4.5 New England Dermal Fillers and Botulinum Toxin Status and Prospect (2012-2022)
  1.4.6 The South Dermal Fillers and Botulinum Toxin Status and Prospect (2012-2022)
  1.4.7 The Midwest Dermal Fillers and Botulinum Toxin Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dermal Fillers and Botulinum Toxin (2012-2022)
  1.5.1 United States Dermal Fillers and Botulinum Toxin Sales and Growth Rate (2012-2022)
  1.5.2 United States Dermal Fillers and Botulinum Toxin Revenue and Growth Rate (2012-2022)

2 UNITED STATES DERMAL FILLERS AND BOTULINUM TOXIN MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Dermal Fillers and Botulinum Toxin Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dermal Fillers and Botulinum Toxin Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dermal Fillers and Botulinum Toxin Average Price by Players/Suppliers (2012-2017)
2.4 United States Dermal Fillers and Botulinum Toxin Market Competitive Situation and Trends
  2.4.1 United States Dermal Fillers and Botulinum Toxin Market Concentration Rate
  2.4.2 United States Dermal Fillers and Botulinum Toxin Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DERMAL FILLERS AND BOTULINUM TOXIN SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Dermal Fillers and Botulinum Toxin Sales and Market Share by Region (2012-2017)
3.2 United States Dermal Fillers and Botulinum Toxin Revenue and Market Share by Region (2012-2017)
3.3 United States Dermal Fillers and Botulinum Toxin Price by Region (2012-2017)

4 UNITED STATES DERMAL FILLERS AND BOTULINUM TOXIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Dermal Fillers and Botulinum Toxin Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dermal Fillers and Botulinum Toxin Revenue and Market Share by Type (2012-2017)
4.3 United States Dermal Fillers and Botulinum Toxin Price by Type (2012-2017)
4.4 United States Dermal Fillers and Botulinum Toxin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DERMAL FILLERS AND BOTULINUM TOXIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Dermal Fillers and Botulinum Toxin Sales and Market Share by Application (2012-2017)
5.2 United States Dermal Fillers and Botulinum Toxin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DERMAL FILLERS AND BOTULINUM TOXIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Allergan plc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Allergan plc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Galderma SA
  6.2.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Galderma SA Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merz Pharma GmbH & Co. KGaA
  6.3.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Anika Therapeutics, Inc.
  6.5.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 LG Life Sciences
  6.6.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Suneva Medical, Inc.
  6.7.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Hyaltech
  6.8.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hyaltech Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Speciality European Pharma
  6.9.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Speciality European Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 HUGEL, Inc.
  6.10.2 Dermal Fillers and Botulinum Toxin Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 HUGEL, Inc. Dermal Fillers and Botulinum Toxin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Grex Pharma SaS
6.12 Daewoong Pharmaceuticals
6.13 Medy-Tox Inc.
6.14 TEOXANE Laboratories
6.15 SciVision Biotech Inc.

7 DERMAL FILLERS AND BOTULINUM TOXIN MANUFACTURING COST ANALYSIS

7.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dermal Fillers and Botulinum Toxin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DERMAL FILLERS AND BOTULINUM TOXIN MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Dermal Fillers and Botulinum Toxin Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dermal Fillers and Botulinum Toxin Sales Volume Forecast by Type (2017-2022)
11.3 United States Dermal Fillers and Botulinum Toxin Sales Volume Forecast by Application (2017-2022)
11.4 United States Dermal Fillers and Botulinum Toxin Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Dermal Fillers and Botulinum Toxin
Figure United States Dermal Fillers and Botulinum Toxin Market Size (K Units) by Type (2012-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume Market Share by Type (Product Category) in 2016
Figure Hyaluronic Acid Based Dermal Fillers Product Picture
Figure Non-hyaluronic Acid Based Dermal Fillers Product Picture
Figure Botulinum Toxin Product Picture
Figure United States Dermal Fillers and Botulinum Toxin Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Dermal Fillers and Botulinum Toxin by Application in 2016
Figure Aesthetic Volume Restoration Examples
Table Key Downstream Customer in Aesthetic Volume Restoration
Figure Wrinkle Reduction Examples
Table Key Downstream Customer in Wrinkle Reduction
Figure United States Dermal Fillers and Botulinum Toxin Market Size (Million USD) by Region (2012-2022)
Figure The West Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales (K Units) and Growth Rate (2012-2022)
Figure United States Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dermal Fillers and Botulinum Toxin Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dermal Fillers and Botulinum Toxin Sales Share by Players/Suppliers
Figure 2017 United States Dermal Fillers and Botulinum Toxin Sales Share by Players/Suppliers
Figure United States Dermal Fillers and Botulinum Toxin Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dermal Fillers and Botulinum Toxin Revenue Share by Players/Suppliers
Figure 2017 United States Dermal Fillers and Botulinum Toxin Revenue Share by Players/Suppliers
Table United States Market Dermal Fillers and Botulinum Toxin Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Dermal Fillers and Botulinum Toxin Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Dermal Fillers and Botulinum Toxin Market Share of Top 3 Players/Suppliers
Figure United States Dermal Fillers and Botulinum Toxin Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dermal Fillers and Botulinum Toxin Product Category
Table United States Dermal Fillers and Botulinum Toxin Sales (K Units) by Region (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales Share by Region (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Share by Region (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Market Share by Region in 2016
Table United States Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Revenue Share by Region (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Revenue Market Share by Region in 2016
Table United States Dermal Fillers and Botulinum Toxin Price (USD/Unit) by Region (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales Share by Type (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Share by Type (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2016
Table United States Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dermal Fillers and Botulinum Toxin by Type (2012-2017)
Figure Revenue Market Share of Dermal Fillers and Botulinum Toxin by Type in 2016
Table United States Dermal Fillers and Botulinum Toxin Price (USD/Unit) by Types (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Growth Rate by Type (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2012-2017)
Table United States Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2016
Table United States Dermal Fillers and Botulinum Toxin Sales Growth Rate by Application (2012-2017)
Figure United States Dermal Fillers and Botulinum Toxin Sales Growth Rate by Application (2012-2017)
Table Allergan plc. Basic Information List
Table Allergan plc. Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan plc. Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Allergan plc. Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Allergan plc. Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Galderma SA Basic Information List
Table Galderma SA Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Galderma SA Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Galderma SA Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Galderma SA Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Merz Pharma GmbH & Co. KGaA Basic Information List
Table Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Merz Pharma GmbH & Co. KGaA Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Sanofi Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Sanofi Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Anika Therapeutics, Inc. Basic Information List
Table Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Anika Therapeutics, Inc. Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure LG Life Sciences Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure LG Life Sciences Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Suneva Medical, Inc. Basic Information List
Table Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Suneva Medical, Inc. Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Hyaltech Basic Information List
Table Hyaltech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hyaltech Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Hyaltech Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Hyaltech Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Speciality European Pharma Basic Information List
Table Speciality European Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Speciality European Pharma Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure Speciality European Pharma Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure Speciality European Pharma Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table HUGEL, Inc. Basic Information List
Table HUGEL, Inc. Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure HUGEL, Inc. Dermal Fillers and Botulinum Toxin Sales Growth Rate (2012-2017)
Figure HUGEL, Inc. Dermal Fillers and Botulinum Toxin Sales Market Share in United States (2012-2017)
Figure HUGEL, Inc. Dermal Fillers and Botulinum Toxin Revenue Market Share in United States (2012-2017)
Table Grex Pharma SaS Basic Information List
Table Daewoong Pharmaceuticals Basic Information List
Table Medy-Tox Inc. Basic Information List
Table TEOXANE Laboratories Basic Information List
Table SciVision Biotech Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermal Fillers and Botulinum Toxin
Figure Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
Figure Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
Table Raw Materials Sources of Dermal Fillers and Botulinum Toxin Major Players/Suppliers in 2016
Table Major Buyers of Dermal Fillers and Botulinum Toxin
Table Distributors/Traders List
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Type in 2022
Table United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Application in 2022
Table United States Dermal Fillers and Botulinum Toxin Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Dermal Fillers and Botulinum Toxin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dermal Fillers and Botulinum Toxin Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories